PALBOCICLIB for Bone cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 493 adverse event reports in the FDA FAERS database where PALBOCICLIB was used for Bone cancer.
Most Reported Side Effects for PALBOCICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 15,190 | 16.7% | 522 | 1,889 |
| White blood cell count decreased | 11,273 | 12.4% | 420 | 1,505 |
| Neoplasm progression | 10,885 | 12.0% | 1,499 | 1,400 |
| Death | 8,410 | 9.2% | 8,384 | 556 |
| Nausea | 8,189 | 9.0% | 346 | 1,395 |
| Neutropenia | 6,423 | 7.1% | 313 | 759 |
| Alopecia | 6,201 | 6.8% | 137 | 619 |
| Diarrhoea | 5,635 | 6.2% | 187 | 983 |
| Asthenia | 3,660 | 4.0% | 320 | 920 |
| Off label use | 3,405 | 3.7% | 353 | 451 |
| Decreased appetite | 3,400 | 3.7% | 238 | 757 |
| Pain | 3,384 | 3.7% | 179 | 698 |
| Malaise | 3,294 | 3.6% | 199 | 710 |
| Dyspnoea | 3,178 | 3.5% | 304 | 1,116 |
| Vomiting | 3,060 | 3.4% | 236 | 929 |
Other Indications for PALBOCICLIB
Breast cancer metastatic (18,160)
Breast cancer female (17,915)
Breast cancer (13,075)
Product used for unknown indication (2,475)
Neoplasm malignant (1,996)
Breast cancer stage iv (1,232)
Metastases to bone (556)
Hormone receptor positive her2 negative breast cancer (386)
Invasive ductal breast carcinoma (332)
Breast cancer recurrent (318)
Other Drugs Used for Bone cancer
LENALIDOMIDE (342)
CABOZANTINIB S-MALATE (328)
DENOSUMAB (219)
ENZALUTAMIDE (213)
PAZOPANIB (182)
ERLOTINIB (174)
CAPECITABINE (143)
BEVACIZUMAB (140)
POMALIDOMIDE (114)
ABEMACICLIB (90)